Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: A retrospective cohort study

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Auer Hackenberg, Lorenz ^a   Staudinger, Thomas ^a   Bojic, Andja ^a   Locker, Gottfried ^a   Leitner, Gerda C ^a   Graninger, Wolfgang ^a   Winkler, Stefan ^a   Ramharter, Michael ^a,b   Worel, Nina ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Automated red blood cell exchange; Cytapheresis; Erythrocytapheresis; Erythrocyte transfusion; Malaria; Plasmodium falciparum; Severe malaria; Whole blood exchange transfusion

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; AUSTRIA; AUTOMATION; BLOOD COMPONENT THERAPY; CHILD; CLINICAL DECISION MAKING; COHORT ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; ERYTHROCYTAPHERESIS; FEMALE; GENERAL HOSPITAL; HEMODYNAMICS; HOSPITAL ADMINISTRATOR; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MORTALITY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AUSTRIA; AUTOMATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HOSPITALS, GENERAL; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITEMIA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860559360     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-158     Document Type: Article

References (34)

1. WHO, Guidelines for the treatment of malaria WHO, Geneva Second 2010
2. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group, Lancet 2005 366 717 725 16125588 (Pubitemid 41207233)
3. Acute renal failure in patients with severe falciparum malaria. Trang TT, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TT, Mai NT, Waller DJ, White NJ, Clin Infect Dis 1992 15 874 880 10.1093/clind/15.5.874 1445988
4. The use of drotrecogin alfa in severe falciparum malaria. Robak O, Bojic A, Locker GJ, Laczika K, Ramharter M, Staudinger T, Anaesth Intensive Care 2010 38 751 754 20715743
5. Pyronaridine-artesunate combination therapy for the treatment of malaria. Kurth F, Bélard S, Basra A, Ramharter M, Curr Opin Infect Dis 2011 24 564 569 10.1097/QCO.0b013e32834cabdb 21986615
6. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Ramharter M, Oyakhirome S, Klein Klouwenberg P, Adégnika AA, Agnandji ST, Missinou MA, Matsiégui PB, Mordmüller B, Borrmann S, Kun JF, Lell B, Krishna S, Graninger W, Issifou S, Kremsner PG, Clin Infect Dis 2005 40 1777 1784 10.1086/430309 15909266 (Pubitemid 40799947)
7. Routine anticonvulsants for treating cerebral malaria. Meremikwu M, Marson AG, Cochrane Database Syst Rev 2002 2 D002152 12076440
8. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Brandts CH, Ndjavé M, Graninger W, Kremsner PG, Lancet 1997 350 704 709 10.1016/S0140-6736(97)02255-1 9291905 (Pubitemid 27371169)
9. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T, N Engl J Med 1982 306 313 319 10.1056/NEJM198202113060601 7033788 (Pubitemid 12169111)
10. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. Miller KD, Greenberg AE, Campbell CC, N Engl J Med 1989 321 65 70 10.1056/NEJM198907133210201 2659994 (Pubitemid 19170393)
11. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Riddle MS, Jackson JL, Sanders JW, Blazes DL, Clin Infect Dis 2002 34 1192 1198 10.1086/339810 11941545 (Pubitemid 34450666)
12. Automated erythrocyte exchange in fulminant falciparum malaria. Files JC, Case CJ, Morrison FS, Ann Intern Med 1984 100 396 6364911
13. Rapid increases in parasitemia following red cell exchange for malaria. Watanaboonyongcharoen P, Park YA, Poisson JL, Brecher ME, J Clin Apher 2011 26 315 319 10.1002/jca.20309 21964823
14. Automated erythrocytapheresis for severe falciparum malaria. Harris P, Price S, Senthuran S, Cochupanachimootil J, Norton R, Intern Med J 2011 41 60 63 10.1111/j.1445-5994.2010.02362.x 21265962
15. Eritrocitaféresis automatizada en el tratamiento de la malaria grave: estudio de 6 pacientes. Fernández-Fuertes LF, Tapia-Martín M, Angel-Moreno A, Pisos-Alamo E, Losada-Castillo MC, Díaz-Cremades JM, Pérez-Arellano JL, Med Clin (Barc) 2008 131 298 301
16. Automated erythrocytapheresis in severe falciparum malaria: A critical appraisal. Nieuwenhuis JA, Meertens JH, Zijlstra JG, Ligtenberg JJ, Tulleken JE, van der Werf TS, Acta Trop 2006 98 201 206 10.1016/j.actatropica.2006.05.003 16765312 (Pubitemid 44066282)
17. Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers. Macallan DC, Pocock M, Robinson GT, Parker-Williams J, Bevan DH, Trans R Soc Trop Med Hyg 2000 94 353 356 10.1016/S0035-9203(00)90101-9 11127231 (Pubitemid 30662336)
18. Treatment of severe malaria by exchange transfusion. Vachon F, Wolff M, Clair B, Regnier B, N Engl J Med 1990 322 58 59 2403649 (Pubitemid 20023839)
19. Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Mordmüller B, Kremsner PG, Clin Infect Dis 1998 26 850 852 10.1086/513926 9564462
20. Exchange transfusion in sickle cell disease using a continuous-flow blood cell separator. Kernoff LM, Botha MC, Jacobs P, Transfusion 1977 17 269 271 10.1046/j.1537-2995.1977.17377196364.x 867470 (Pubitemid 8155196)
21. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, J Clin Apher 2010 25 83 177 10.1002/jca.20240 20568098
22. UK malaria treatment guidelines. Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA, J Infect 2007 54 111 121 10.1016/j.jinf.2006.12.003 17215045 (Pubitemid 46083312)
23. Treatment of malaria in the United States: a systematic review. Griffith KS, Lewis LS, Mali S, Parise ME, JAMA 2007 297 2264 2277 10.1001/jama.297.20. 2264 17519416 (Pubitemid 47018065)
24. Consensus statement-Malaria Prävention, Diagnostik und Therapie. Kollaritsch H, Ramharter M, Thalhammer F, Gattringer R, Haditsch M, Hollenstein U, Kobbe R, Körner C, Krause R, Laferl H, Nödl H, Robak O, Schmutzhard E, Staudinger T, Weiss G, Wenisch C, Winkler S, rztezeitung http://www.oeginfekt.at/download/cs-malaria.pdf
25. Communicable Diseases Cluster. WHO: Severe falciparum malaria. World Health Organization, Trans R Soc Trop Med Hyg 2000 94 Suppl 1 1 90 10748883
26. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Ramharter M, Wernsdorfer WH, Kremsner PG, Acta Trop 2004 90 55 60 10.1016/j.actatropica.2003.11.001 14739023 (Pubitemid 38117056)
27. Jahresstatistik meldepflichtiger Infektionskrankheiten ab 2000 http://www.bmg.gv.at/home/Schwerpunkte/Krankheiten/Uebertragbare-Krankheiten/ Statistiken/Jahresstatistik-meldepflichtiger-Infektionskrankheiten-ab-2000
28. Blood examination and prognosis in acute falciparum malaria. Field JW, Trans R Soc Trop Med Hyg 1949 43 33 48 10.1016/0035-9203(49)90022-X 18139104
29. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP, PLoS Med 2005 2 204 10.1371/journal.pmed.0020204 16104831 (Pubitemid 46179250)
30. Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients. Ramharter M, Willheim M, Winkler H, Wahl K, Lagler H, Graninger W, Winkler S, Parasite Immunol 2003 25 211 219 10.1046/j.1365-3024. 2003.00628.x 12940964 (Pubitemid 38019294)
31. Delayed parasite elimination in human infections treated with clindamycin parallels delayed death of Plasmodium falciparum in vitro. Burkhardt D, Wiesner J, Stoesser N, Ramharter M, Uhlemann AC, Issifou S, Jomaa H, Krishna S, Kremsner PG, Borrmann S, Int J Parasitol 2007 37 777 785 10.1016/j.ijpara.2006. 12.010 17280676 (Pubitemid 46654006)
32. In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Ramharter M, Noedl H, Winkler H, Graninger W, Wernsdorfer WH, Kremsner PG, Winkler S, Antimicrob Agents Chemother 2003 47 3494 3499 10.1128/AAC.47.11.3494-3499.2003 14576107 (Pubitemid 37345709)
33. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
34. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S, J Infect Dis 2005 192 1830 1835 10.1086/497337 16235185 (Pubitemid 41587837)